Posted by Michael Wonder on 14 Nov 2024
EMA publishes agenda for 11-14 November 2024 CHMP meeting
11 November 2024 - - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Aflibercept
- Repotrectinib
- Coacillium
- Vilobelimab
- Sipavibart
- Temozolomide
- Lazertinib
- Denosumab
